A new application of sound resonance technology therapy for the treatment of fibromyalgia: A retrospective analysis

This study explores the use of Sound Resonance Technology Therapy (SRTT) as a treatment for fibromyalgia. The three-phase protocol—combining vibroacoustic sessions, psychotherapy, and integration support—led to significant and sustained symptom relief in most patients. Within one month, average FIQ scores dropped by 26 points, with further improvement over a year. Results suggest that SRTT helps release emotional trauma stored in the body, contributing to physical healing. While promising, the study’s retrospective nature highlights the need for randomized controlled trials to confirm its effectiveness.

Read More

1. Sound Resonance Technology Therapy (SRTT) Shows Strong Potential for Fibromyalgia Relief

  • A three-phase SRTT protocol was studied in 131 patients with fibromyalgia (FM).
  • The treatment led to a rapid and significant reduction in symptoms, particularly within the first month.
  • On average, patients’ FIQ (Fibromyalgia Impact Questionnaire) scores dropped by 26 points in one month.

2. The Treatment Includes Three Integrated Phases

  • Phase 1: 10-day sound resonance sessions using vibroacoustic therapy.
  • Phase 2: Intensive 2–4 week psychotherapy ("Psycho-coaching") to help process emotional content that surfaced during sound therapy.
  • Phase 3: Long-term integration phase lasting up to 11 months, involving lifestyle and behavior modification.

3. The Mechanism is Based on Emotional and Neurological Reprocessing

  • SRTT is built on the "disregulation model", linking emotional processing with physical health.
  • It leverages sound and vibration to stimulate neurological imprints and long-term memory.
  • These imprints often carry psychological trauma that can manifest physically—particularly in FM.

4. Long-Term Symptom Improvement Was Observed

  • Among those who completed long-term follow-up, FIQ score reductions were sustained for up to 6–8 years.
  • After 1 year, patients showed a mean score reduction of 38 points, suggesting lasting benefit.

5. Clinical Outcomes Were Stronger Than Other FM Treatments

  • Compared to programs from the Mayo Clinic and other studies, SRTT produced greater reductions across multiple FIQ subscales, such as:
  • Pain
  • Fatigue
  • Morning tiredness
  • Stiffness
  • Anxiety and depression
  • 50% of patients saw a 50%+ improvement in their FIQ scores in just one month.